b12 store tirzepatide Compound with *Cold Chain Product Compounded Tirzepatide with B12 -

Semaglutide (Wegovy and Ozempic) is an FDA-approved GLP-1 agonist that is used to treat obesity, type 2 diabetes, and weight-related health conditions such as metabolic dysfunction-associated steatohepatitis (MASH)

Within indication-based subgroups, tirzepatide used in patients with diabetes mellitus was significantly more frequently associated with gastrointestinal disorders compared with patients in weight control purpose

State-licensed pharmacies operating under Section 503A had until April 22, 2025, to cease production of compounded semaglutide that essentially copies the FDA-approved products

Dosage varies by patient